De Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8:e180–90.

Article  PubMed  Google Scholar 

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Troppan K, Wenzl K, Neumeister P, Deutsch A. Molecular Pathogenesis of MALT Lymphoma. Gastroenterol Res Pract. 2015;2015:1–10.

Article  Google Scholar 

Rossi D, Bertoni F, Zucca E. Marginal-Zone Lymphomas. N Engl J Med. 2022;386:568–81.

Article  CAS  PubMed  Google Scholar 

Hu Q, Zhang Y, Zhang X, Fu K. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management. Biomark Res. 2016;4:15.

Article  PubMed  PubMed Central  Google Scholar 

Köller MC, Aigelsreiter A. Chlamydia psittaci in ocular adnexal MALT lymphoma: a possible causative agent in the pathogenesis of this disease. Curr Clin Micro Rpt. 2018;5:261–7.

Article  Google Scholar 

Travaglino A, Varricchio S, Pace M, Russo D, Picardi M, Baldo A, et al. Borrelia burgdorferi in primary cutaneous lymphomas: a systematic review and meta-analysis. J Deutsche Derma Gesell. 2020;18:1379–84.

Google Scholar 

Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107:3034–44.

Article  CAS  PubMed  Google Scholar 

Adam P, Czapiewski P, Colak S, Kosmidis P, Tousseyn T, Sagaert X, et al. Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe. Br J Haematol. 2014;164:804–10.

Article  CAS  PubMed  Google Scholar 

Borie R, Wislez M, Antoine M, Copie-Bergman C, Thieblemont C, Cadranel J. Pulmonary mucosa-associated lymphoid tissue lymphoma revisited. Eur Respir J. 2016;47:1244–60.

Article  CAS  PubMed  Google Scholar 

Fenollar F, Lagier J-C, Raoult D. Tropheryma whipplei and Whipple’s disease. J Infect. 2014;69:103–12.

Article  PubMed  Google Scholar 

Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, et al. The HLA Alleles DRB1*13 and DQB1*06 Are Associated to Whipple’s Disease. Gastroenterology. 2009;136:2289–94.

Article  CAS  PubMed  Google Scholar 

Schöniger-Hekele M, Petermann D, Weber B, Müller C. Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol. 2007;73:2033–5.

Article  PubMed  PubMed Central  Google Scholar 

Dolmans RAV, Boel CHE, Lacle MM, Kusters JG. Clinical manifestations, treatment, and diagnosis of tropheryma whipplei infections. Clin Microbiol Rev. 2017;30:529–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruffer N, Holzer M-T, Gkanatsas Y, Schinglerová I, Boro D, Krusche M, et al. Chronische tropheryma-whipplei-infektion: eine wichtige Differentialdiagnose der therapierefraktären Polyarthritis. Z Rheumatol. 2023;82:885–91.

Article  CAS  PubMed  Google Scholar 

Jutant E-M, Roche A, Boucly A, Camboulive A, Jevnikar M, Jais X, et al. Whipple’s disease: a rare and life-threatening cause of pulmonary hypertension. Pulmonary hypertension [Internet]. European Respiratory Society; 2021 [cited 2023 Dec 29]. p. PA3599. Available from: http://erj.ersjournals.com/lookup/doi/https://doi.org/10.1183/13993003.congress-2021.PA3599

Gillen CD, Coddington R, Monteith PG, Taylor RH. Extraintestinal lymphoma in association with Whipple’s disease. Gut. 1993;34:1627–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gruner U, Goesch P, Donner A, Peters U. Morbus Whipple und Non-Hodgkin-Lymphom. Z Gastroenterol. 2001;39:305–9.

Article  CAS  PubMed  Google Scholar 

Cadenas F, Sánchez-Lombraña JL, Pérez R, Lomo FJ, Madrigal Rubiales B, Vivas S, et al. Persistent leucocytosis as initial manifestation of Whipple’s disease and development of gastric cancer in the follow up. Rev Esp Enferm Dig. 1999;91:785–8.

CAS  PubMed  Google Scholar 

Wang S, Ernst LM, Smith BR, Tallini G, Howe JG, Crouch J, et al. Systemic Tropheryma whippleii infection associated with monoclonal B-cell proliferation: a Helicobacter pylori-type pathogenesis? Arch Pathol Lab Med. 2003;127:1619–22.

Article  PubMed  Google Scholar 

Vela V, Juskevicius D, Dirnhofer S, Menter T, Tzankov A. Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. Virchows Arch. 2022;480:403–13.

Article  CAS  PubMed  Google Scholar 

Nienhold R, Mensah N, Frank A, Graber A, Koike J, Schwab N, et al. Unbiased screen for pathogens in human paraffin-embedded tissue samples by whole genome sequencing and metagenomics. Frontiers in Cellular and Infection Microbiology [Internet]. 2022 [cited 2024 Jan 6];12. Available from: https://www.frontiersin.org/articles/https://doi.org/10.3389/fcimb.2022.968135

Talwalkar SS, Valbuena JR, Abruzzo LV, Admirand JH, Konoplev SN, Bueso-Ramos CE, et al. MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast. Mod Pathol. 2006;19:1402–8.

Article  CAS  PubMed  Google Scholar 

Ivanova V-S, Davies J, Menter T, Wild D, Müller A, Krasniqi F, et al. Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis. Histopathology. 2024;84:525–38.

Article  PubMed  Google Scholar 

Vela V, Juskevicius D, Prince SS, Cathomas G, Dertinger S, Diebold J, et al. Deciphering the genetic landscape of pulmonary lymphomas. Mod Pathol. 2021;34:371–9.

Article  CAS  PubMed  Google Scholar 

Nienhold R, Ciani Y, Koelzer VH, Tzankov A, Haslbauer JD, Menter T, et al. Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nat Commun. 2020;11:5086.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sauter C, Kurrer MO. Intracellular bacteria in Hodgkin’s disease and sclerosing mediastinal B-cell lymphoma: Sign of a bacterial etiology? Swiss Med Wkly. 2002;132:312–5.

PubMed  Google Scholar 

Tison A, Preuss P, Leleu C, Robin F, Le Pluart A, Vix J, et al. Rheumatological features of Whipple disease. Sci Rep. 2021;11:12278.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crayne CB, Albeituni S, Nichols KE, Cron RQ. The Immunology of Macrophage Activation Syndrome. Frontiers in Immunology [Internet]. 2019 [cited 2023 Dec 26];10. Available from: https://www.frontiersin.org/articles/https://doi.org/10.3389/fimmu.2019.00119

Desnues B, Ihrig M, Raoult D, Mege J-L. Whipple’s disease: a macrophage disease. Clin Vaccine Immunol. 2006;13:170–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lagier J-C, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore). 2010;89:337–45.

Article  PubMed  Google Scholar 

Marth T. Tropheryma whipplei, Immunosuppression and whipple’s disease: from a low-pathogenic, environmental infectious organism to a rare. Multifaceted Inflamm Complex Dig Dis. 2015;33:190–9.

Google Scholar 

Marth T. Complicated Whipple’s disease and endocarditis following tumor necrosis factor inhibitors. World J Cardiol. 2014;6:1278–84.

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Xiang J, Li X, Blankson S, Zhao S, Cai J, et al. NF-κB activation is critical for bacterial lipoprotein tolerance-enhanced bactericidal activity in macrophages during microbial infection. Sci Rep. 2017;7:40418.

Article  PubMed  PubMed Central